Benefit–risk evaluation of COVID-19 vaccination in special population groups of interest - Sorbonne Université Access content directly
Journal Articles Vaccine Year : 2022

Benefit–risk evaluation of COVID-19 vaccination in special population groups of interest

Paul Moss
  • Function : Author
Francis Berenbaum
Giuseppe Curigliano
  • Function : Author
Ayelet Grupper
  • Function : Author
Thomas Berg
  • Function : Author
Shanti Pather
  • Function : Author

Dates and versions

hal-03994741 , version 1 (17-02-2023)

Identifiers

Cite

Paul Moss, Francis Berenbaum, Giuseppe Curigliano, Ayelet Grupper, Thomas Berg, et al.. Benefit–risk evaluation of COVID-19 vaccination in special population groups of interest. Vaccine, 2022, 40 (32), pp.4348-4360. ⟨10.1016/j.vaccine.2022.05.067⟩. ⟨hal-03994741⟩
5 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More